374 related articles for article (PubMed ID: 8877311)
1. New directions in the drug treatment of Parkinson's disease.
Montastruc JL; Rascol O; Senard JM
Drugs Aging; 1996 Sep; 9(3):169-84. PubMed ID: 8877311
[TBL] [Abstract][Full Text] [Related]
2. Treatment options for early Parkinson's disease.
Stacy M; Brownlee HJ
Am Fam Physician; 1996 Mar; 53(4):1281-7. PubMed ID: 8629572
[TBL] [Abstract][Full Text] [Related]
3. [Dopaminergic agonists in the treatment of Parkinson's disease].
Supiot F; Sternon J; Zegers de Beyl D
Rev Med Brux; 2000 Dec; 21(6):493-9. PubMed ID: 11194495
[TBL] [Abstract][Full Text] [Related]
4. Controversies in the treatment of Parkinson's disease.
Hely MA; Morris JG
Curr Opin Neurol; 1996 Aug; 9(4):308-13. PubMed ID: 8858190
[TBL] [Abstract][Full Text] [Related]
5. Parkinson's disease--levodopa complications.
King DB
Can J Neurol Sci; 1999 Aug; 26 Suppl 2():S13-20. PubMed ID: 10451755
[TBL] [Abstract][Full Text] [Related]
6. Selegiline in Parkinson's disease.
Calne DB
BMJ; 1995 Dec; 311(7020):1583-4. PubMed ID: 8555790
[No Abstract] [Full Text] [Related]
7. Moderate Parkinson's disease. Strategies for maximizing treatment.
Silverstein PM
Postgrad Med; 1996 Jan; 99(1):52-4, 61-3, 67-8, passim. PubMed ID: 8539210
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Parkinson's disease.
Lieberman A
Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):339-43. PubMed ID: 8507903
[TBL] [Abstract][Full Text] [Related]
9. Advances in managing Parkinson's disease.
Waters CH
Hosp Pract (1995); 2001 Jun; 36(6):27-32, 41. PubMed ID: 11419534
[TBL] [Abstract][Full Text] [Related]
10. Parkinson's disease: drug therapy.
Oertel WH; Quinn NP
Baillieres Clin Neurol; 1997 Apr; 6(1):89-108. PubMed ID: 9426870
[TBL] [Abstract][Full Text] [Related]
11. Attempts to obtain neuroprotection in Parkinson's disease.
Olanow CW
Neurology; 1997 Jul; 49(1 Suppl 1):S26-33. PubMed ID: 9222272
[TBL] [Abstract][Full Text] [Related]
12. Early therapy for Parkinson's disease.
Olanow CW
Eur Neurol; 1992; 32 Suppl 1():30-5. PubMed ID: 1358615
[TBL] [Abstract][Full Text] [Related]
13. [Stage-adjusted treatment of idiopathic Parkinson syndrome].
Ludin HP
Wien Med Wochenschr; 1995; 145(13):294-8. PubMed ID: 7571654
[TBL] [Abstract][Full Text] [Related]
14. Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease.
Hauser RA; Koller WC; Hubble JP; Malapira T; Busenbark K; Olanow CW
Mov Disord; 2000 May; 15(3):485-9. PubMed ID: 10830413
[TBL] [Abstract][Full Text] [Related]
15. Are dopamine receptor agonists neuroprotective in Parkinson's disease?
Le WD; Jankovic J
Drugs Aging; 2001; 18(6):389-96. PubMed ID: 11419913
[TBL] [Abstract][Full Text] [Related]
16. Effects of increasing doses of apomorphine during stereotaxic neurosurgery in Parkinson's disease: clinical score and internal globus pallidus activity. Short communication.
Stefani A; Stanzione P; Bassi A; Mazzone P; Vangelista T; Bernardi G
J Neural Transm (Vienna); 1997; 104(8-9):895-904. PubMed ID: 9451721
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of Parkinson disease. 1: Standard therapy of motor and non-motor symptoms].
Kuhn W; Müller T
Fortschr Neurol Psychiatr; 1997 Aug; 65(8):361-74. PubMed ID: 9378449
[TBL] [Abstract][Full Text] [Related]
18. Pallidotomy in Parkinson's disease.
Temlett JA
S Afr Med J; 1996 Oct; 86(10):1248-9. PubMed ID: 8955725
[No Abstract] [Full Text] [Related]
19. Drug treatment of Parkinson's disease.
Quinn N
BMJ; 1995 Mar; 310(6979):575-9. PubMed ID: 7888935
[TBL] [Abstract][Full Text] [Related]
20. Early Parkinson's disease: what is the best approach to treatment.
Hristova AH; Koller WC
Drugs Aging; 2000 Sep; 17(3):165-81. PubMed ID: 11043817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]